Evidence map›Paper›PMID 26160654›Full record

ReviewEMBO reports2015

Presynaptic active zones in invertebrates and vertebrates.

Frauke Ackermann, Clarissa L Waites, Craig C Garner

Abstract readReview
In one paragraph

Review in EMBO reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed.

  1. Article
  2. Molecular Physiology of the Neuronal Synapse.Current issues in molecular biology · 2026
    Review
  3. Review
  4. Article
  5. CRISPR-edited iPSCs reveal BSN gene mutations induce neuronal hyperexcitability via astrocyte lipid accumulation.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  6. Article
  7. Article
  8. Imaging Synapse Ultrastructure and Organization with STED Microscopy.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  9. Article
  10. Review
  11. RIM and RIM-Binding Protein Localize Synaptic CaV2 Channels to Differentially Regulate Transmission in Neuronal Circuits.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  12. Review
  13. Article
  14. The Biological Significance of Trogocytosis.Results and problems in cell differentiation · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. NMJ-related diseases beyond the congenital myasthenic syndromes.Frontiers in cell and developmental biology · 2023
    Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Frauke AckermannGerman Center for Neurodegenerative Disease, Charité Medical University, Berlin, Germany.
Clarissa L WaitesDepartment of Pathology and Cell Biology, Columbia University, New York, NY, USA.
Craig C GarnerGerman Center for Neurodegenerative Disease, Charité Medical University, Berlin, Germany craig-curtis.garner@dzne.de.

Funding

Uncovering the Roles of Ubiquitination and the ESCRT Pathway in Degradative Sorting of SV Proteins.R01NS080967 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WAITES, CLARISSA LEIGH · 2013 to 2023
$3.8M
NINDS NIH HHS NS080967NINDS NIH HHS R01 NS080967
6 · The paper itself

Abstract

The regulated release of neurotransmitter occurs via the fusion of synaptic vesicles (SVs) at specialized regions of the presynaptic membrane called active zones (AZs). These regions are defined by a cytoskeletal matrix assembled at AZs (CAZ), which functions to direct SVs toward docking and fusion sites and supports their maturation into the readily releasable pool. In addition, CAZ proteins localize voltage-gated Ca(2+) channels at SV release sites, bringing the fusion machinery in close proximity to the calcium source. Proteins of the CAZ therefore ensure that vesicle fusion is temporally and spatially organized, allowing for the precise and reliable release of neurotransmitter. Importantly, AZs are highly dynamic structures, supporting presynaptic remodeling, changes in neurotransmitter release efficacy, and thus presynaptic forms of plasticity. In this review, we discuss recent advances in the study of active zones, highlighting how the CAZ molecularly defines sites of neurotransmitter release, endocytic zones, and the integrity of synapses.

Indexed as

Synaptic TransmissionAnimalsCaenorhabditis elegansCalciumCytoskeletonInvertebratesNerve Tissue ProteinsNeurotransmitter AgentsPresynaptic TerminalsSynapsesSynaptic VesiclesUltrasonographyVertebratesCalciumNerve Tissue ProteinsNeurotransmitter Agentsactive zonecytoskeletal matrixfusionreleasesynaptic vesicle

Identifiers

PMID26160654
PMCPMC4552486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.